Gene · 5928
Papers2,308
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,308
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Migrasome and cancer - from cellular to clinical perspectives. | Biomark Res | 2026 | 41545844 | PubTator, text mining | PubMed |
| Translational evaluation of BUB1B as a precision medicine biomarker for hepatocellular carcinoma. | Sci Rep | 2026 | 41545558 | PubTator, text mining | PubMed |
| Therapeutic horizons in the development of PROTAC-based EZH2 inhibitors: recent achievements, comparative analysis, and future perspectives. | RSC Adv | 2026 | 41541203 | PubTator, text mining | PubMed |
| Development of a split-toxin CRISPR screening platform to systematically identify regulators of human myoblast fusion. | Nat Commun | 2026 | 41540035 | PubTator, text mining | PubMed |
| Comprehensive Genomic Profiling of Advanced Anal Adenocarcinoma in Japan. | JCO Precis Oncol | 2026 | 41538763 | PubTator, text mining | PubMed |
| Designing single-atom catalysts: bridging metal-support interaction and adsorption energy optimization. | Chem Sci | 2026 | 41531773 | PubTator, text mining | PubMed |
| Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients. | BMC Med | 2026 | 41530754 | PubTator, text mining | PubMed |
| Identification of a Musashi2 translocation as a novel oncogene in myeloid leukemia. | Elife | 2026 | 41498402 | PubTator, text mining | PubMed |
| Emerging structural insights into PRC2 function in development and disease. | Trends Biochem Sci | 2026 | 41372031 | PubTator, text mining | PubMed |
| Clinicopathological features and mutational landscape of colorectal cancer subgroups defined by MSI and EMAST status. | Pathol Res Pract | 2026 | 41308359 | PubTator, text mining | PubMed |
| Histone chaperones as potential epidrug targets against cancer. | Nucleosides Nucleotides Nucleic Acids | 2026 | 40059533 | PubTator, text mining | PubMed |
| Mass spectrometry in ocular drug research. | Mass Spectrom Rev | 2026 | 37530668 | PubTator, text mining | PubMed |
| Radiomics in sporadic microsatellite instable, mismatch repair deficient and Lynch syndrome-associated pancreatic ductal adenocarcinoma: a pilot study. | Front Oncol | 2025 | 41800453 | PubTator, text mining | PubMed |
| The effect of African ancestry and mismatch-repair enzyme deficiency/microsatellite instability-high on colorectal adenocarcinoma immune gene expression. | Front Gastroenterol (Lausanne) | 2025 | 41640699 | PubTator, text mining | PubMed |
| [A Case of MSI-High Locally Advanced Colorectal Cancer with Pathological Complete Response to Pembrolizumab]. | Gan To Kagaku Ryoho | 2025 | 41546335 | PubTator, text mining | PubMed |
| [A Case of Locally Advanced Gastric Cancer with Pathological Complete Response after Chemotherapy Including Immune Checkpoint Inhibitors]. | Gan To Kagaku Ryoho | 2025 | 41546304 | PubTator, text mining | PubMed |
| [A Case of Simultaneous Resection of Single Lung and Liver Metastases with Combined Immunotherapy after Radical Surgery for Hepatocellular Carcinoma]. | Gan To Kagaku Ryoho | 2025 | 41546261 | PubTator, text mining | PubMed |
| Targeting Esophageal Cancer: Promising Drugs for the Clinical Landscape and Key Knowledge Gaps. | Drug Des Devel Ther | 2025 | 41502549 | PubTator, text mining | PubMed |
| Enhancing cardiomyocyte reprogramming efficiency by targeting cellular senescence is mediated via Rb1 gene. | Stem Cell Res Ther | 2025 | 41462332 | PubTator, text mining | PubMed |
| Early mutational events and clonal dynamics in normal crypts: implications for colorectal tumorigenesis. | Hum Genomics | 2025 | 41392153 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5928/papers?page=6